NMTC stock forecast now incorporates revised GDP growth estimates, which tend to correlate positively with telecom infrastructure spending. Economists expect Q3 macro conditions to remain supportive, bolstering revenue projections. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies insiders are buying, and this list of stocks growth stocks (according to analyst forecasts) Boston Scientific reported second-quarter 2025 adjusted EPS of 75 cents, beating the Zacks Consensus Estimate by 4.2%. Revenues of $5.06 billion surpassed the Zacks Consensus Estimate by 3.5%. It currently carries a Zacks Rank #2 (Buy). Short-term NMTC stock forecast momentum is supported by RSI readings below overbought levels, leaving room for further gains without immediate correction pressure. Options data also shows rising call interest for near-term expirations.